John Murphy, CEO, COVID-19 Long-haul Foundation I. Abstract The persistence of symptoms following acute SARS-CoV-2 infection—commonly referred to as long COVID—has emerged as a global health crisis. Among the most […]
Lifelong drugs for autoimmune diseases don’t work well. Now scientists are trying something new
LAURAN NEERGAARD CAR-T therapy was originally developed for leukemias and lymphomas, and the breakthrough treatment is now also being used for autoimmune diseases. Here’s a look at how the powerful […]
Long COVID in 2025: Latest Research, Symptoms, and Treatment Advances
By Editorial Team – One Day MD.com More than four years following the emergence of COVID-19, a subset of individuals experience persistent, multisystem symptoms extending beyond three months post-infection or post-exposure to […]
Study Finds Long COVID Disrupts Brain Adaptability and Emotional Health
Muhammad Tuhin, Science News Daily It starts quietly for many. A lingering headache. A missed word. A mental blank where a memory used to be. Months, even years after recovering […]
🧠 Post-Acute Sequelae of SARS-CoV-2 Infection and Epstein-Barr Virus Reactivation
John Murphy, CEO The COVID-19 Long-haul Foundation 📄 Abstract Background: Post-acute sequelae of SARS-CoV-2 infection (PASC), commonly referred to as long COVID, is characterized by persistent symptoms beyond 12 weeks […]
🧠 Neurovascular and Genomic Underpinnings of COVID-19 Brain Fog: A Multisystem Analysis of Etiology, Pathophysiology, and Therapeutic Targets
John Murphy, CEO, The COVID-19 Long-haul Foundation Abstract COVID-19 brain fog, a hallmark of post-acute sequelae of SARS-CoV-2 infection (PASC), represents a complex neurocognitive syndrome characterized by impaired memory, attention, […]
Influenza A (H1N1) and COVID-19 Pneumonias: An Evaluation in the Light of New Hematologic Indices
Yeşildağ M , Kocabas R, DOI https://doi.org/10.2147/JIR.S54538 Objective: Influenza A (H1N1) and COVID-19 viruses are two very different airway viral pneumonia agents that cause similar clinical manifestations and coinfections. The aim of this […]
Dysgeusia in Long COVID: Etiology, Physiology, Pathology, and Therapeutic Horizons
Author: John Murphy, CEO The COVID-19 Long-haul Foundation Abstract Taste disturbance has emerged as one of the most persistent and distressing sequelae of SARS‑CoV‑2 infection. While anosmia and ageusia were […]
Vestibular Dysfunction in COVID-19 Infection and Vaccination: Etiology, Physiology, and Pathology
John Murphy, M.D., MPH, DPH, President The COVID19 Long-haul Foundation Abstract COVID-19 and its vaccines have been associated with vestibular symptoms including vertigo, dizziness, and cognitive impairment (“brain fog”). This […]
Dimensional Distribution of mRNA Vaccine-Derived Spike Proteins: Etiology, Physiology, and Pathological Risk Profiles
John Murphy, MD CEO & President, COVID-19 Long-haul Foundation Abstract Messenger RNA (mRNA) vaccines have revolutionized infectious disease prevention, yet their biodistribution and systemic effects remain incompletely characterized. This article […]